| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/14/1995 | US5389670 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 02/14/1995 | US5389668 Thiochroman compounds |
| 02/14/1995 | US5389655 Treats angina pectoris |
| 02/14/1995 | US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives |
| 02/09/1995 | WO1995004051A1 Piperazine compounds used in therapy |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/08/1995 | CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/08/1995 | CN1098312A Method for preparation of traditional Chinese medicine for treating nephritis |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387603 1,5,7-trisubstituted indoline compounds and salts thereof |
| 02/06/1995 | CA2129483A1 Bicyclic derivatives of imidazole, process for their preparation, new intermediate compounds thus obtained, their application as medicaments, and pharmaceutical compositions containing them |
| 02/04/1995 | CA2129301A1 Benzo-fused heterocyclic compounds with a 5-membered ring, process for their preparation, their use as medicaments, their use as diagnostic agents, and medicaments containing them |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003295A1 Endothelin antagonists |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167410A1 Endothelin antagonists |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/01/1995 | EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 02/01/1995 | EP0636614A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 02/01/1995 | EP0528997B1 Disulfide derivatives of mercaptoacylamino acids |
| 02/01/1995 | EP0469125B1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
| 02/01/1995 | EP0404797B1 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS |
| 01/31/1995 | US5385930 Treating central nervous system disorders like anxiety and depression |
| 01/31/1995 | US5385917 Carboxylic acid derivatives |
| 01/31/1995 | US5385898 Hypertensive agents; cardiovascular disorders; renin inhibitors; glaucoma |
| 01/31/1995 | CA2129215A1 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 01/31/1995 | CA2129214A1 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives |
| 01/26/1995 | WO1995002609A1 Peptides exhibiting oxytocin antagonistic activity |
| 01/26/1995 | WO1995002593A1 Piperazine derivatives and salts thereof |
| 01/26/1995 | WO1995002587A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| 01/26/1995 | WO1995002408A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 01/26/1995 | CA2166974A1 Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| 01/26/1995 | CA2166873A1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 01/26/1995 | CA2163114A1 Peptides exhibiting oxytocin antagonistic activity |
| 01/26/1995 | CA2143203A1 Piperazine derivatives and salts thereof |
| 01/25/1995 | EP0635519A1 Polyglucuronic acid as remitting agent for nephrotic syndrome and hepatopathy symptoms |
| 01/25/1995 | EP0516849B1 Indole derivatives |
| 01/25/1995 | CN1027504C Imidazolyl-alkenoic acids |
| 01/24/1995 | US5384327 Anticonvulsant sorbopyranose sulfamates |
| 01/24/1995 | CA2038410C Tenidap as an inhibitor of the release of elastage by neutrophils |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/18/1995 | EP0633781A1 Compositions and methods for treating benign prostatic hypertrophy |
| 01/18/1995 | EP0633723A1 Use of hydriodic acid as an aphrodisiac |
| 01/18/1995 | CN1097419A New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained |
| 01/17/1995 | US5382598 Therapeutic amides |
| 01/17/1995 | US5382585 Treatment of cardiovascular disorders and erectile dysfunctions |
| 01/17/1995 | US5382569 Hexapeptides for cardiovascular disorders |
| 01/16/1995 | CA2127934A1 Remitting agent for nephrotic syndrome and hepatopathy symptoms |
| 01/12/1995 | WO1995001374A1 Synthetic peptides of human papillomavirus |
| 01/12/1995 | WO1995001353A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 01/12/1995 | WO1995001183A1 Compositions for nasal administration of desmopressin |
| 01/12/1995 | CA2166333A1 Synthetic peptides of human papillomavirus |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine |
| 01/11/1995 | EP0633023A2 Preventing emesis and treating sexual dysfunction using tetrahydrobenz CD indole-6-carboxamides |
| 01/11/1995 | CN1027370C Process for production of thiazole derivatives |
| 01/10/1995 | US5380921 Aminophosponic acid derivative |
| 01/10/1995 | US5380757 Method of treating vulvar dystrophy and vaginal dryness |
| 01/10/1995 | US5380750 Arylethylamine compounds |
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/05/1995 | WO1995000844A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 01/05/1995 | WO1995000548A1 Biologically active vasopressin analogues |
| 01/05/1995 | WO1995000517A1 Process for producing imidazole derivative |
| 01/05/1995 | WO1995000477A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2163352A1 Biologically active vasopressin analogues |
| 01/04/1995 | EP0632033A1 Novel benzopyran derivative |
| 01/04/1995 | CN1027270C 14,17 beta-ehano-14 beta-estratrienes and estratetranenes, process for their production and pharmaceutical preparations containing them |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378720 Treatment of rheumatoid arthritis, emphysema, pancreatitis |
| 12/28/1994 | EP0630372A1 Heteroalkoxy benzazepines |
| 12/27/1994 | US5376637 Pharmaceutical preparation containing vasoactive intestinal polypeptide or its analogue |
| 12/27/1994 | US5376553 Analyzing biological fluid samples for presence of dicitrate cyclic diester which indicates no pathological calcification or predisposition towards it |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
| 12/22/1994 | WO1994029280A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028902A1 Pyrazolopyrimidinones for the treatment of impotence |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | CA2161325A1 Pyrimidine, cyanoguandines as k-channel blockers |
| 12/22/1994 | CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/21/1994 | EP0629408A1 Combination of angiotensin converting enzyme inhibitors and AII antagonists |
| 12/21/1994 | EP0629405A1 Agent for inhibiting a decrease in bone mass in renal osteodystrophy |
| 12/21/1994 | EP0629129A1 Method for kidney tubulogenesis |